EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte StudieOpen access · CC BY-NC-ND 4.0

Potential Choroidal Mechanisms Underlying Atropine's Antimyopic and Rebound Effects: A Mediation Analysis in a Randomized Clinical Trial

Hannan Xu, Luyao Ye, Yajun Peng, Tao Yu, Shanshan Li, Shijun Weng, Yelin Huang, Yuzhong Chen, Ying Fan, Haidong Zou, Jiangnan He, Jianfeng Zhu and 1 more

Investigative Opthalmology & Visual Science · 2023-04-12 · 64 (4) · 13

DOI: 10.1167/iovs.64.4.13 ↗

At a glance

Randomisierte kontrollierte Studie in Investigative Opthalmology & Visual Science, published on 2023-04-12. Written by Hannan Xu and 12 co-authors. Institution: Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye D…. Major MEDLINE topics: Atropine, Choroid, Mediation Analysis, Tomography, Optical Coherence. Cited 15 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Purpose

To investigate whether choroidal vascularity participates in high-dose atropine's antimyopia and rebound mechanisms.

Methods

A mediation analysis was embedded within a randomized controlled trial. In total, 207 myopic children were assigned randomly to group A/B. Participants in group A received 1% atropine weekly (phase 1) and 0.01% atropine daily (phase 2) for 6 months each. Those in group B received 0.01% atropine daily for 1 year. Four plausible intervention mediators were assessed: total choroidal area (TCA), luminal area (LA), stromal area (SA), and choroidal vascularity index (CVI).

Results

In group A, LA, SA, and TCA increased significantly after receiving 1% atropine for 6 months. The increment diminished after tapering to 0.01% atropine. In group B, those parameters remained stable. TCA mediated approximately one-third of 1% atropine's effect on spherical equivalent progression in both phases. In phase 1, the mediation effect of TCA was shared by LA and SA, while only that of LA remained significant in phase 2. No mediation effect of CVI was found.

Conclusions

One percent atropine induced choroidal thickening by increasing both LA and SA, while 0.01% atropine had little choroidal response. The choroidal changes following 1% atropine treatment diminished after switching to 0.01% atropine. TCA, but not CVI, partially explains atropine's antimyopic and myopic-rebound mechanisms. SA may serve as a potential biomarker to predict the postrebound treatment efficacy of high-dose atropine. (ClinicalTrials.gov number, NCT03949101.).

Subjects

MeSH terms (MEDLINE)

AtropineChoroidMediation AnalysisTomography, Optical CoherenceMyopiaChildHumansRefraction, Ocular

Substances

Atropine

Authors and institutions

  • Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, National Clinical Research Center for Eye Diseases, Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai E…
  • Shanghai Eye Disease Prevention and Treatment Center, Shanghai Eye Hospital, Shanghai, China.
  • State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, Shanghai, China.
  • Beijing Airdoc Technology Co., Ltd., Beijing, China.

Cite

APA

Xu, H., Ye, L., Peng, Y., Yu, T., Li, S., Weng, S., Huang, Y., Chen, Y., Fan, Y., Zou, H., He, J., Zhu, J., & Xu, X. (2023). Potential Choroidal Mechanisms Underlying Atropine's Antimyopic and Rebound Effects: A Mediation Analysis in a Randomized Clinical Trial. Investigative Opthalmology & Visual Science, 64(4), 13. https://doi.org/10.1167/iovs.64.4.13

Vancouver

Xu H, Ye L, Peng Y, Yu T, Li S, Weng S, et al. Potential Choroidal Mechanisms Underlying Atropine's Antimyopic and Rebound Effects: A Mediation Analysis in a Randomized Clinical Trial. Investigative Opthalmology & Visual Science. 2023;64(4):13. doi:10.1167/iovs.64.4.13

BibTeX
@article{Xu2023,
  author = {Xu, Hannan and Ye, Luyao and Peng, Yajun and Yu, Tao and Li, Shanshan and Weng, Shijun and Huang, Yelin and Chen, Yuzhong and Fan, Ying and Zou, Haidong and He, Jiangnan and Zhu, Jianfeng and Xu, Xun},
  title = {Potential Choroidal Mechanisms Underlying Atropine's Antimyopic and Rebound Effects: A Mediation Analysis in a Randomized Clinical Trial},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2023},
  volume = {64},
  number = {4},
  pages = {13},
  doi = {10.1167/iovs.64.4.13}
}
Start for free →